- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01504737
Rehabilitation in Aortic Stenosis Patients (RASP)
Rehabilitation in the Form of Exercise Training in Aortic Stenosis Patients (RASP)
SURVEY OF THE FIELD Aortic stenosis (AS) is the most common valve disease and increasing due to a growing elderly population. The therapy is aortic valve replacement (AVR). Studies on postoperative rehabilitation of AS pts are scarce. In the few studies available, a mix of valve diseases is presented without considering the differences in pathophysiology and the training regimes are not clearly described.
PURPOSE, AIMS & HYPOTHESIS The investigators purpose is to evaluate whether a supervised cardiac rehabilitation program improves the objective physical capacity and quality of life (QoL) of patients after AVR due to AS, and compare this to patients training by their own. The investigators hypothesize that supervised exercise training may be a more efficient way of rehabilitating these patients.
DESIGN This is a controlled randomized clinical trial comparing 12 weeks of supervised exercise training 3 times per week to home-based training based upon public health recommendations of minimum level of physical activity.
SIGNIFICANCE & IMPLEMENTATION Positive results would support that an organized program of exercise training improves physical capacity and QoL in AS patients following AVR with potential benefit for both patients and society.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Östergötland
-
Linköping, Östergötland, Sweden
- Heart and Medicine Center, Linköping University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Elective surgery with aortic valve replacement for aortic stenosis at the thoracic surgery department at Linköping University hospital, Linköping.
- Geographical residence no further from hospital than permitting visit to Supervised Exercise Training 3 times per week
Exclusion Criteria:
- Any concommitant heart disease
- Other surgical intervention at time of valve replacement
- Age under 18 years
- Symptomatic lung disease
- Any disability or disease hampering participation in exercise training
- Cannot communicate with spoken Swedish
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Supervised Exercise Training
12 weeks of 40 min aerobic bicycle ergometer exercise 3 times per week.
|
12 weeks of endurance training, 40 minutes, 3 times per week on ergometer bicycle.
Other Names:
|
ACTIVE_COMPARATOR: Physical Activity Recommendations
Written and verbal information on minimal level of physical activity recommended.
|
Written and verbal information on minimal level of physical activity recommended.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in peak oxygen uptake
Time Frame: Before (within one week before intervention), 1 week after and 12 months after intervention
|
Physical capacity measured with cardiopulmonary exercise testing (CPET) on bicycle ergometer.
|
Before (within one week before intervention), 1 week after and 12 months after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Health-related Quality of Life
Time Frame: Before (within one week before intervention), 1 week after and 12 months after intervention
|
Short-form 36, version 2
|
Before (within one week before intervention), 1 week after and 12 months after intervention
|
Change in Physical activity level
Time Frame: Before (within one week before intervention), 1 week after and 12 months after intervention
|
PAL - Physical activity level, measured with International Physical Activity Questionnary (IPAQ)
|
Before (within one week before intervention), 1 week after and 12 months after intervention
|
Change in hs-CRP
Time Frame: Before (within one week before intervention), 1 week after and 12 months after intervention
|
Before (within one week before intervention), 1 week after and 12 months after intervention
|
|
Change in NT-pro-BNP
Time Frame: Before (within one week before intervention), 1 week after and 12 months after intervention
|
Before (within one week before intervention), 1 week after and 12 months after intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Eva Nylander, PhD, Linkoeping University
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RASP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Valve Stenosis
-
Anteris Technologies Ltd.Active, not recruitingAortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisGeorgia
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
The Medicines CompanyCompletedTranscatheter Aortic Valve Replacement | Aortic Valve Replacement | Severe Aortic StenosisNetherlands, Germany, United Kingdom, Canada, France, Italy, Switzerland
-
Ningbo Jenscare Biotechnology Co., Ltd.UnknownAortic Regurgitation | Severe Aortic Stenosis
-
Edwards LifesciencesCompletedAortic Valve Stenosis | Aortic Valve Stenosis With Insufficiency | Regurgitation, Aortic Valve | Aortic Valve IncompetenceUnited States
-
Sorin Group USA, Inc.TerminatedAortic Valve Stenosis | Aortic Valve Stenosis With Insufficiency | Regurgitation, Aortic Valve | Aortic Valve IncompetenceUnited States
-
Edwards LifesciencesActive, not recruitingAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
BC Centre for Improved Cardiovascular HealthEdwards LifesciencesUnknownTranscatheter Aortic Valve Implantation | Severe Aortic StenosisCanada
-
Genesis Medtech CorporationRecruitingDiseases of Aortic Valve | Aortic Stenosis DiseaseChina
-
Edwards LifesciencesActive, not recruitingHeart Failure | Aortic Stenosis | Mitral Valve Insufficiency | Aortic Valve Insufficiency | Mitral StenosisUnited States, Canada, Poland
Clinical Trials on Aerobic Exercise Training
-
UNC Lineberger Comprehensive Cancer CenterCompletedStem Cell Transplantation, HematopoieticUnited States
-
National Taiwan University HospitalCompletedAtrial FibrillationTaiwan
-
Riphah International UniversityCompletedSpinal Cord InjuriesPakistan
-
University of HoustonTerminated
-
Istanbul University - Cerrahpasa (IUC)CompletedObstructive Sleep Apnea SyndromeTurkey
-
University of Alberta, Physical EducationCanadian Breast Cancer Research AllianceCompleted
-
Chang Gung Memorial HospitalCompleted
-
Chang Gung Memorial HospitalUnknownStroke Patients With Cognitive DeclineTaiwan
-
Federal University of UberlandiaSuspendedHypertension | Dyslipidemias | Multimorbidity | Multiple Chronic ConditionsBrazil
-
Universitätsmedizin MannheimUnknownMorbid ObesityGermany